Related Experiment Videos
Delayed life-threatening reaction to anthrax vaccine
B Swanson-Biearman1, E P Krenzelok
1Pittsburgh Poison Center, Children's Hospital of Pittsburgh, Pennsylvania 15213, USA.
Journal of Toxicology. Clinical Toxicology
|May 1, 2001
Summary
A rare, severe reaction to the anthrax vaccine occurred in a military member, highlighting the need for emergency preparedness. While most reactions are mild, this case shows serious adverse events are possible.
Area of Science:
- Immunology
- Vaccinology
- Public Health
Background:
- Anthrax, caused by Bacillus anthracis, is a significant biodefense concern.
- Department of Defense mandates anthrax vaccination for all US military personnel.
- Most anthrax vaccine recipients experience mild, localized reactions.
Observation:
- A case report details a 34-year-old male experiencing severe adverse events post-anthrax vaccination.
- Symptoms included dyspnea, diaphoresis, pallor, and urticarial wheals.
- These serious systemic reactions occurred after the third vaccine dose.
Findings:
- The patient's severe reaction resolved with pharmacological intervention.
- Delayed, life-threatening adverse events following anthrax vaccination are possible.
- Emergency physicians must be prepared for rare, severe vaccine reactions.
Implications:
- Increased vigilance and preparedness for rare adverse events are crucial for military health.
- Understanding potential severe reactions informs clinical management and public health strategies.
- This case underscores the importance of monitoring vaccine safety in large populations.